These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27181729)

  • 21. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
    Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
    J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
    Vasilevko V; Cribbs DH
    Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translating research on brain aging into public health: a new type of immunotherapy for Alzheimer's disease.
    Lannfelt L; Pettersson FE; Nilsson LN
    Nutr Rev; 2010 Dec; 68 Suppl 2():S128-34. PubMed ID: 21091946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neuroimmunologist's perspective on Alzheimer's disease therapy.
    Solomon B
    Expert Rev Neurother; 2007 May; 7(5):439-41. PubMed ID: 17492893
    [No Abstract]   [Full Text] [Related]  

  • 25. The immune response in the Alzheimer's disease brain.
    Banati RB
    Biochem Soc Trans; 1997 May; 25(2):683-5. PubMed ID: 9191182
    [No Abstract]   [Full Text] [Related]  

  • 26. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wired.
    Underwood E
    Science; 2016 Aug; 353(6301):762-5. PubMed ID: 27540162
    [No Abstract]   [Full Text] [Related]  

  • 28. Hopes remain for an Alzheimer's vaccine.
    Schenk D
    Nature; 2004 Sep; 431(7007):398. PubMed ID: 15385984
    [No Abstract]   [Full Text] [Related]  

  • 29. Microglia and the immune pathology of Alzheimer disease.
    Giulian D
    Am J Hum Genet; 1999 Jul; 65(1):13-8. PubMed ID: 10364511
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy in Alzheimer's disease: where do we stand? Where should we go?
    von Bernhardi R
    J Alzheimers Dis; 2010; 19(2):405-21. PubMed ID: 20110590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demystifying the immune system and autoimmune disease.
    Ohio Nurses Foundation
    Ohio Nurses Rev; 2005; 80(6):18-22; quiz 23-4. PubMed ID: 16528893
    [No Abstract]   [Full Text] [Related]  

  • 32. Antimicroglia antibodies in sera of Alzheimer's disease patients.
    Lemke MR; Glatzel M; Henneberg AE
    Biol Psychiatry; 1999 Feb; 45(4):508-11. PubMed ID: 10071725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Premature immunosenescence: a pathogenetic factor in Alzheimer's disease?].
    Richartz-Salzburger E; Stransky E; Laske C; Köhler N
    Nervenarzt; 2010 Jul; 81(7):837-43. PubMed ID: 20386875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-amyloid immunisation in Alzheimer's disease.
    Sorbi S
    Neurol Sci; 2005 May; 26 Suppl 1():S5. PubMed ID: 15883696
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunotherapeutic approaches to Alzheimer's disease.
    Monsonego A; Weiner HL
    Science; 2003 Oct; 302(5646):834-8. PubMed ID: 14593170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid cells in Alzheimer's disease: culprits, victims or innocent bystanders?
    Meyer-Luehmann M; Prinz M
    Trends Neurosci; 2015 Oct; 38(10):659-668. PubMed ID: 26442698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.
    Raivich G; Banati R
    Brain Res Brain Res Rev; 2004 Nov; 46(3):261-81. PubMed ID: 15571769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier.
    Banks WA
    Immunotherapy; 2010 Jan; 2(1):1-3. PubMed ID: 20635884
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy as treatment for Alzheimer's disease.
    Hawkes CA; McLaurin J
    Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction.
    Badoer E
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1580-5. PubMed ID: 20638485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.